Related Experiment Video
Updated: Jul 15, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
KLF11 in Extracellular Vesicles Derived from adMSCs Inhibits Colorectal Cancer via Suppressing SOAT1-Mediated
Fan Yang1, Haitao Yu1, Jian Ni1
1General Surgery Fourth Ward, The First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang Province, P.R. China.
Abstract:
Colorectal cancer (CRC) remains one of the most frequently diagnosed and lethal malignancies. Recent studies showed that either adipose-derived mesenchymal stem cells (adMSCs) or the extracellular vesicles (EVs) they secrete retarded CRC progression. Here, we investigated the mechanism underlying the role of adMSCs-EVs in CRC. Here, we found that Krüppel-like factor 11 (KLF11) was upregulated in adMSCs-EVs. adMSCs-EVssh-KLF11 (EVs derived from KLF11-depleted adMSCs) effectively promoted lipogenesis, cell viability, proliferation, migration, and invasion of CRC cells, and accelerated tumor growth in mice. Furthermore, KLF11 carried by adMSCs-EVs dampened the PI3K/AKT signaling pathway by transcriptionally repressing sterol o-acyltransferase 1 (SOAT1) expression. SOAT1 knockdown blocked the enhanced lipogenesis, proliferation, migration and invasion induced by adMSCs-EVssh-KLF11. In conclusion, KLF11 derived from adMSCs-EVs inactivated the PI3K/AKT signaling pathway by transcriptionally downregulating SOAT1, therefore suppressing lipogenesis and malignant progression of CRC.
Insights
Adipose-derived mesenchymal stem cell extracellular vesicles (adMSCs-EVs) suppress colorectal cancer (CRC) progression. Krüppel-like factor 11 (KLF11) in adMSCs-EVs inhibits cancer growth by downregulating SOAT1 and the PI3K/AKT pathway.
Area of Science:
- Oncology
- Stem Cell Biology
- Molecular Biology
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality.
- Adipose-derived mesenchymal stem cells (adMSCs) and their secreted extracellular vesicles (EVs) show potential in retarding CRC progression.
Purpose of the Study:
- To elucidate the mechanism by which adMSCs-EVs influence CRC progression.
- To investigate the role of Krüppel-like factor 11 (KLF11) within adMSCs-EVs in CRC.
Main Methods:
- Analysis of KLF11 expression in adMSCs-EVs.
- In vitro and in vivo experiments using adMSCs-EVs and KLF11-depleted adMSCs-EVs (adMSCs-EVssh-KLF11).
- Investigation of the PI3K/AKT signaling pathway and sterol o-acyltransferase 1 (SOAT1) expression.
Main Results:
- KLF11 was upregulated in adMSCs-EVs.
- adMSCs-EVssh-KLF11 promoted CRC cell lipogenesis, viability, proliferation, migration, invasion, and accelerated tumor growth.
- adMSCs-EVs-derived KLF11 suppressed the PI3K/AKT pathway by repressing SOAT1 transcription.
- SOAT1 knockdown mimicked the pro-tumorigenic effects of adMSCs-EVssh-KLF11.
Conclusions:
- KLF11 delivered by adMSCs-EVs inhibits CRC progression.
- The mechanism involves the inactivation of the PI3K/AKT signaling pathway via transcriptional downregulation of SOAT1.
- This process suppresses lipogenesis and malignant behaviors in colorectal cancer cells.

